- Published on
KembaraXtra-Emergency and Acute Medicine - Opiate Poisoning
Description: Opiates bind to μ, κ, and δ receptors in the central and peripheral nervous systems, producing analgesia, sedation, and respiratory depression. Both physical and psychological dependence can develop. Peak plasma levels occur within 1–2 hours after oral ingestion, 30–60 minutes after intramuscular use, and seconds to minutes after intravenous or intranasal exposure.
Etiology: Opiate poisoning most commonly results from overuse or abuse of prescription analgesics used for moderate to severe pain. Street preparations may be adulterated with substances such as cocaine, clenbuterol, phencyclidine, strychnine, dextromethorphan, quinine, or scopolamine, which can alter clinical presentation and severity.
Clinical features: Central nervous system effects include somnolence, CNS depression, coma, and seizures. Respiratory depression, apnea, bronchospasm, and noncardiogenic pulmonary edema may occur. Cardiovascular manifestations include hypotension, bradycardia, and palpitations. Gastrointestinal findings include nausea, vomiting, and constipation. Other classic features include miosis and hypothermia. Withdrawal presents with hypertension, tachycardia, tachypnea, abdominal cramps, diarrhea, piloerection, yawning, and agitation. Neonates exposed in utero may develop withdrawal within 12–72 hours after birth, presenting with irritability, tremors, poor feeding, and dehydration. Diphenoxylate toxicity is particularly dangerous in children and may be fatal.
Evaluation: Continuous monitoring of vital signs and respiratory status is essential in significant exposures. Pulse oximetry or arterial blood gases should be obtained, with chest radiography performed for persistent hypoxia, pulmonary edema, or aspiration. Abdominal radiographs are indicated if body packing is suspected. A thorough physical examination should include inspection for occult opioid patches such as fentanyl.
Diagnostic testing: Plasma opioid levels are not clinically useful and treatment is guided by presentation. Urine toxicology screens may fail to detect synthetic opioids such as methadone. An acetaminophen level must be obtained in all suspected oral opioid overdoses due to frequent coformulation and risk of occult toxicity.
Management: Initial management prioritizes airway protection, oxygen supplementation, and circulatory support. Naloxone should be administered promptly to reverse respiratory depression and coma, with cautious low-dose titration in opioid-dependent patients to avoid severe withdrawal. Repeated dosing or continuous infusion may be required for long-acting opioids such as methadone or fentanyl. Endotracheal intubation is indicated if respiratory depression persists despite naloxone. Activated charcoal may be given for recent oral ingestion if the airway is protected. Whole-bowel irrigation with polyethylene glycol is recommended for asymptomatic body packers. Hypotension is treated with intravenous fluids and vasopressors if refractory. Seizures are treated initially with benzodiazepines, followed by phenobarbital if needed. Opioid withdrawal may be managed with clonidine or methadone.
Disposition and follow-up: Admission is required for patients with persistent symptoms, need for repeated naloxone dosing or infusion, body packers, young children after diphenoxylate ingestion, or suspected coingestants. Patients may be discharged if asymptomatic after appropriate observation—6 hours after oral overdose or 4 hours after naloxone administration—and after confirmed elimination of opioid packets when applicable. All patients should receive substance abuse referral, poison prevention counseling for accidental exposures, and psychiatric evaluation for intentional ingestions.
Pearls and pitfalls: Always consider occult acetaminophen poisoning in chronic opioid users. Synthetic and semisynthetic opioids may not appear on standard urine drug screens. Buprenorphine can cause prolonged sedation in children. Used opioid patches still contain clinically significant drug amounts and may cause severe toxicity.
- Published on
KembaraXtra-Emergency and Acute Medicine - Noncardiogenic Pulmonary Edema
Description: Noncardiogenic pulmonary edema (NCPE) results from accumulation of protein-rich fluid within the alveoli due to increased permeability of the alveolar-capillary membrane rather than elevated pulmonary capillary pressure (>18 mm Hg). Functional disruption of this membrane allows fluid and protein to move freely into the alveolar space. Although pulmonary parenchymal changes may resemble congestive heart failure, cardiomegaly, pleural effusions, and cephalad blood flow redistribution are typically absent. Pulmonary capillary pressure is ≤18 mm Hg, and alveolar fluid protein concentration mirrors that of intravascular fluid. Adult respiratory distress syndrome (ARDS) is the classic form of NCPE, often developing within 1–2 hours of a noxious insult and associated with severe physiologic impairment.
Etiology: ARDS is the most common cause and may result from sepsis, pneumonia, nonthoracic trauma, inhaled toxins, disseminated intravascular coagulation, or radiation pneumonitis. Other causes include high-altitude pulmonary edema, neurogenic pulmonary edema, narcotic overdose, pulmonary embolism, eclampsia, transfusion-related acute lung injury, rapid re-expansion of a pneumothorax, salicylate intoxication, inhaled cocaine use, near drowning, hydrochlorothiazide use, uremia, and post–cardiopulmonary bypass states, particularly in patients receiving amiodarone.
Clinical features: Patients commonly present with acute shortness of breath, fatigue, weakness, cough, and malaise. Examination reveals hypoxia, dyspnea, tachypnea, tachycardia, accessory muscle use, scattered rales or rhonchi, and sometimes pink frothy sputum. Signs of left- or right-sided heart failure such as peripheral edema or cardiomegaly are typically absent.
Evaluation: History and physical examination usually distinguish NCPE from cardiogenic pulmonary edema. Chest radiography is essential for confirmation and severity assessment; early imaging may be normal but often progresses to a bilateral “butterfly” alveolar pattern without cardiomegaly. Laboratory abnormalities are nonspecific. When measured, pulmonary artery catheterization shows normal or near-normal pulmonary capillary wedge pressures.
Differential diagnosis: Cardiogenic pulmonary edema, diffuse alveolar hemorrhage, pneumonia, pulmonary embolism, COPD exacerbation, restrictive lung disease, and diffuse malignant infiltration such as lymphoma or leukemia.
Management: Treatment is supportive and directed at the underlying cause. Maintain airway patency and provide adequate oxygenation with supplemental oxygen, IV access, continuous cardiac monitoring, and pulse oximetry. Diuretics are not indicated and may worsen outcomes. Noninvasive ventilation with CPAP or BiPAP may be used in stable patients; failure to improve requires endotracheal intubation. Mechanical ventilation should use lung-protective strategies with low tidal volumes (6–8 mL/kg) and PEEP of 5–10 cm H₂O. Begin with 100% oxygen and titrate based on arterial oxygenation. Steroids and cyclooxygenase inhibitors have not demonstrated benefit. In suspected high-altitude pulmonary edema, prompt descent, supplemental oxygen, hyperbaric therapy, and adjunctive nifedipine are recommended.
Disposition and follow-up: All symptomatic patients should be admitted to an intensive care setting, as deterioration may occur for up to 72 hours after the inciting insult. Asymptomatic patients with reversible causes may be observed in the emergency department for 6–12 hours and discharged if oxygenation remains adequate, with medical follow-up arranged within 48 hours.
Pearls and pitfalls: Use of diuretics in acute NCPE may worsen the patient’s condition. Failure to distinguish cardiogenic from noncardiogenic pulmonary edema is a common pitfall, as management strategies differ significantly.
- Published on
Emergency and Acute Medicine – Needlestick Injury
Needlestick and other sharps injuries are a common occupational hazard in healthcare and emergency settings, resulting in potential exposure to blood or body fluids. Exposure can occur through percutaneous injury, mucous membrane contact, or contact with nonintact skin. Prevention remains the cornerstone of management and includes strict adherence to universal precautions, avoidance of needle recapping, consistent glove use (with double gloving when appropriate), and compliance with body–substance isolation protocols. Wearing gloves can reduce the volume of blood exposure by approximately 50%, and hepatitis B vaccination is a critical preventive strategy for all at-risk personnel.
The risk of infection following a single needlestick exposure depends on the pathogen involved, characteristics of the exposure, and host factors. Without prior immunization, the risk of hepatitis B virus (HBV) transmission ranges from 37–62% when the source is HBsAg- and HBeAg-positive, and 23–37% when the source is HBsAg-positive but HBeAg-negative. The risk of hepatitis C virus (HCV) transmission is approximately 1.8%. HIV transmission risk is lower, estimated at 0.3% for percutaneous exposure and 0.09% for mucous membrane exposure. Infectivity also varies by body fluid, with plasma and serum carrying the highest viral concentrations and fluids such as urine, saliva, tears, and vaginal secretions having much lower concentrations. Factors that influence transmission risk include viral load, depth of inoculation, type and size of needle, duration of contact, volume of injected material, portal of entry, host susceptibility, and the presence of protective barriers such as gloves.
Evaluation begins with a detailed history documenting the date, time, and circumstances of exposure, the type of body fluid involved, and information about the source patient if known. Immunization history, particularly hepatitis B vaccination status, must be reviewed. Women of childbearing potential who may require antiviral prophylaxis should undergo pregnancy testing. Baseline laboratory evaluation should ideally be coordinated through occupational health services and includes serologic testing for HIV, HBV, and HCV, along with alanine aminotransferase levels. Consent should be obtained from the source patient, when possible, for HIV, HBV, and HCV testing, including the use of rapid HIV testing when available.
Immediate management focuses on local wound care with copious washing and cleaning of the exposure site. Tetanus prophylaxis should be updated as indicated. Prompt referral to occupational health is preferred to ensure confidentiality and continuity of care; however, if unavailable, evaluation and initiation of postexposure prophylaxis (PEP) should occur in the emergency department without delay. Timely initiation of prophylactic therapy is critical, particularly for HIV exposure, where treatment is most effective when started as soon as possible and continued for 28 days.
HIV postexposure prophylaxis recommendations are guided by the severity of exposure and the HIV status and viral load of the source patient. Depending on these factors, either a basic two-drug regimen or an expanded regimen with three or more antiretroviral agents is recommended. Counseling is an essential component of care and includes advice on safer sex practices, avoidance of pregnancy, blood or tissue donation, and breastfeeding during the follow-up period.
Management of hepatitis B exposure depends on the vaccination and immune status of the exposed individual and the HBV status of the source. Options include no treatment for adequately immunized individuals with protective antibody titers, initiation of the hepatitis B vaccine series for unvaccinated individuals, and administration of hepatitis B immune globulin for high-risk exposures or known nonresponders. In contrast, there is no proven prophylaxis for hepatitis C exposure; immunoglobulin and antiviral agents have not demonstrated consistent benefit, though early identification and treatment of established infection may improve outcomes.
Needlestick injuries rarely require hospital admission and are typically managed on an outpatient basis with close follow-up through occupational medicine services. Clear discharge instructions and follow-up plans are essential to ensure adherence to prophylactic regimens, completion of vaccination series when indicated, and serial testing to monitor for seroconversion.
- Published on
KembaraXtra-Emergency and Acute Medicine - Oculomotor Nerve Palsy
Description: Oculomotor nerve palsy involves dysfunction of the 3rd cranial nerve (CN III) and typically presents with eyelid drooping (ptosis), blurred or double vision, and light sensitivity. CN III controls most eye movements including elevation, depression, and adduction, as well as eyelid elevation and pupillary constriction. Lesions are classified as complete or incomplete and as pupil-involving or pupil-sparing. Complete palsy results in a characteristic “down and out” eye position and is most often due to compressive causes such as aneurysm, tumor, brainstem herniation, or increased intracranial pressure. Incomplete palsy usually reflects ischemic injury to the vasa vasorum and is commonly seen in patients with diabetes or uncontrolled hypertension. Pupil involvement strongly suggests a compressive lesion because parasympathetic fibers are located peripherally in the nerve, whereas pupil sparing favors ischemic etiologies.
Etiology: Causes include intracranial or orbital tumors, aneurysms (especially posterior communicating artery), trauma, intracranial hemorrhage, diabetes mellitus, migraine, infection or meningitis, arteriovenous malformations, cavernous sinus thrombosis, neuropathies such as myasthenia gravis or Guillain–Barré syndrome, collagen vascular diseases including sarcoidosis, and idiopathic causes. In children, trauma is the most common cause of acquired oculomotor nerve palsy.
Clinical features: Symptoms may include diplopia, blurry vision, ptosis, anisocoria, eye pain, and headache. Associated neurologic findings such as hemiplegia, ataxia, tremor, speech changes, or involvement of other cranial nerves raise concern for central pathology. On examination, a pupil-sparing palsy typically shows ptosis and a “down and out” eye with a normal pupil and no additional neurologic deficits, while pupil-involving palsy presents with anisocoria and a dilated, poorly reactive pupil, mandating urgent evaluation for aneurysm or other compressive lesions.
Evaluation: A detailed history focusing on headache, eye pain, pupillary changes, trauma, infection, and vascular risk factors is essential. Physical examination should include full ophthalmologic assessment with extraocular movements, pupillary responses, visual acuity, fundoscopic exam, and evaluation for chemosis, proptosis, or papilledema. Neuroimaging with CT or MRI of the brain, orbits, and sinuses is required. MRI/MRA or CT angiography is particularly indicated when the pupil is involved. Laboratory studies such as CBC, ESR, and autoimmune markers are obtained when vasculitis or systemic disease is suspected. Lumbar puncture may be considered in selected cases.
Management: Initial management focuses on identifying whether the palsy is complete or incomplete and pupil-involving or pupil-sparing. All patients younger than 50 years with any degree of CN III palsy require evaluation for compressive lesions. Pupil-involving palsy mandates urgent neuroimaging and specialist consultation. Pupil-sparing palsy in patients with clear microvascular risk factors may be managed with close outpatient follow-up if imaging is negative. Treatment is directed at the underlying cause and may include blood pressure control, measures to reduce intracranial pressure, antibiotics for meningitis, corticosteroids for inflammatory or vasculitic causes, or neurosurgical intervention when indicated. All children with CN III palsy require MRI/MRA evaluation.
Disposition and follow-up: Admission is required for complete oculomotor nerve palsy of any cause and for incomplete palsy with abnormal imaging, laboratory findings, or additional neurologic deficits. Selected patients with incomplete, pupil-sparing palsy and negative imaging may be discharged with urgent outpatient neurologic follow-up. Prompt follow-up is mandatory for all discharged patients.
Pearls and pitfalls: Pupil involvement is a red flag for compressive lesions and requires immediate imaging. Patients younger than 50 years should not be assumed to have benign ischemic palsy. A careful medication, vascular, and trauma history is critical. Early differentiation between ischemic and compressive causes guides life-saving management.
- Published on
KembaraXtra -Medicine- Nephritic Syndrome
Nephritic syndrome represents acute glomerulonephritis, an inflammatory injury of the glomeruli characterized by abrupt onset of hematuria, often cola- or coffee-colored, with or without red blood cell casts, variable proteinuria, reduced urine output, edema, hypertension, azotemia, and possible acute renal failure. The underlying mechanism is incompletely understood but involves immune-mediated injury to the glomerular basement membrane with crescent formation reflecting severe capillary wall damage.
Poststreptococcal glomerulonephritis is a classic cause and follows infection with group A β-hemolytic streptococci, occurring as a nonsuppurative complication after pharyngitis or skin infection. A latent period of 1–3 weeks after pharyngeal infection or 2–4 weeks after cutaneous infection helps distinguish it from IgA nephropathy. Immune complex deposition produces characteristic subepithelial “hump-shaped” deposits, with low complement C3 levels lasting 6–8 weeks. Prognosis is excellent in most patients, particularly children, with spontaneous recovery of renal function within weeks, although transient nephrotic features may occur during recovery.
Other infectious causes include sepsis, pneumonia, endocarditis, viral infections including HIV, and parasitic diseases such as malaria. Hepatitis virus–associated glomerular disease may present with nephritic or nephrotic features and typically shows persistently low complement levels. Noninfectious immune-mediated causes include systemic lupus erythematosus, Henoch–Schönlein purpura, vasculitis, Goodpasture syndrome, and IgA nephropathy, which is the most common cause worldwide and typically presents with hematuria coinciding with upper respiratory infections and normal complement levels.
Patients commonly present with hematuria, periorbital or generalized edema, hypertension, and symptoms related to recent infection. Children may develop facial edema, whereas older adults may present with congestive heart failure. Nonspecific symptoms such as malaise, anorexia, nausea, and weakness are common. Physical examination often reveals elevated blood pressure and fluid overload.
Evaluation centers on urinalysis showing hematuria, proteinuria, and red blood cell casts, which are diagnostic of active glomerular inflammation. Laboratory studies include complete blood count, renal function tests, serum albumin, complement levels, streptococcal antibody titers, and cultures when infection is suspected. Renal ultrasound assesses kidney size, and chest radiography may reveal pulmonary edema. Renal biopsy is not routinely required for poststreptococcal disease but is indicated for atypical features, persistent hypocomplementemia, severe proteinuria, or progressive renal dysfunction.
Management focuses on treating the underlying cause and controlling complications. Streptococcal infections are treated with appropriate antibiotics. Salt and fluid restriction, loop diuretics for edema, and antihypertensive therapy with ACE inhibitors or ARBs are used to control blood pressure and proteinuria. Severe cases with uremia, electrolyte disturbances, refractory fluid overload, or acidosis require hemodialysis. Hypertensive emergencies are managed with titratable intravenous antihypertensives.
Hospital admission is required for patients with oliguria, rising creatinine, significant edema, electrolyte abnormalities, severe hypertension, heart failure, or suspected systemic disease. Mild cases in otherwise healthy patients may be managed with close outpatient follow-up and nephrology referral. Prognosis is generally favorable, but long-term monitoring of blood pressure, renal function, and proteinuria is essential, particularly in IgA nephropathy and rapidly progressive forms.
- Published on
KembaraXtra -Medicine- Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is a rare, life-threatening neurologic emergency most commonly caused by an adverse reaction to dopamine-blocking antipsychotic medications. Mortality may reach 20%. NMS can occur at any time during neuroleptic therapy, though it most often develops within the first month. The syndrome results from central dopamine receptor blockade, leading to severe skeletal muscle rigidity via the nigrostriatal pathway and hyperthermia from hypothalamic dysfunction. Most cases resolve within two weeks after discontinuation of the offending agent.
NMS is associated with typical and atypical antipsychotics, including high-potency agents such as haloperidol, as well as metoclopramide and promethazine. It may also follow abrupt withdrawal of dopaminergic agents in Parkinson disease. Risk factors include rapid dose escalation, high doses, intravenous administration, dehydration, prior history of NMS, catatonia or agitation, infection, and surgery. Concomitant use of lithium or SSRIs may increase risk.
Clinically, NMS is characterized by hyperthermia, severe “lead-pipe” muscle rigidity, altered mental status ranging from confusion to coma, and autonomic instability. Common findings include tachycardia, labile blood pressure, diaphoresis, tachypnea, dysrhythmias, tremor, dysphagia, incontinence, mutism, and leukocytosis. Temperatures may exceed 41°C (106°F). Complications include rhabdomyolysis, acute renal failure, respiratory failure, and disseminated intravascular coagulation.
Diagnosis is clinical and relies on a careful medication history and physical examination. Laboratory findings typically show markedly elevated creatine kinase, leukocytosis, electrolyte abnormalities, acute kidney injury, elevated liver enzymes, and myoglobinuria. Ancillary testing such as CT, EEG, or lumbar puncture may be required to exclude alternative causes of fever and altered mental status.
The differential diagnosis includes malignant hyperthermia, serotonin syndrome, anticholinergic toxicity, sympathomimetic poisoning, heat stroke, CNS infections, alcohol withdrawal, tetanus, thyrotoxicosis, and withdrawal from intrathecal baclofen. Differentiation is critical, as management strategies differ.
Management centers on immediate discontinuation of all neuroleptic agents and aggressive supportive care. Airway protection, oxygen, cardiac monitoring, rapid cooling measures, and aggressive IV fluid resuscitation are essential. Benzodiazepines are first-line therapy to reduce agitation and muscle rigidity. If rigidity or hyperthermia is uncontrolled, rapid sequence intubation with nondepolarizing neuromuscular blockers is preferred. Bromocriptine and amantadine may be used as dopaminergic agents for ongoing management, while dantrolene may be considered for refractory rigidity, though none have shown definitive mortality benefit.
All patients with suspected NMS require hospital admission, frequently to an intensive care unit. Early recognition, withdrawal of the offending agent, and meticulous supportive management are the most important determinants of outcome. Patients and families must be counseled regarding future avoidance of causative medications, as recurrence risk is significant.
- Published on
KembaraXtra-Emergency and Acute Medicine - Neuroleptic Poisoning
Neuroleptic poisoning refers to toxicity from antipsychotic medications used to treat psychotic disorders, agitation, dementia, autism-related behavioral problems, eating disorders, migraines, and as antiemetics. In acute overdose, symptoms are usually mild to moderate, with central nervous system and cardiovascular effects predominating, though severe toxicity with seizures, coma, or life-threatening complications may occur. Symptom onset is typically within 6 hours but may be delayed up to 24 hours with extended-release preparations such as paliperidone or with agents like aripiprazole.
Typical neuroleptics such as haloperidol, chlorpromazine, prochlorperazine, and droperidol strongly antagonize dopamine receptors and also block histamine, muscarinic, and alpha-adrenergic receptors, contributing to sedation, hypotension, and anticholinergic effects. Atypical neuroleptics including risperidone, olanzapine, quetiapine, clozapine, and ziprasidone have weaker dopamine antagonism with additional serotonergic effects, generally causing less extrapyramidal toxicity but still capable of serious overdose effects.
Clinical manifestations range from mild sedation to coma, with possible anticholinergic delirium, seizures, dystonia, and akathisia. Cardiovascular findings include tachycardia, hypotension, QT prolongation, and rarely torsades de pointes. Respiratory depression and loss of airway reflexes may occur. Dystonic reactions are the most common adverse effect, presenting with involuntary spasms of the face, neck, back, or limbs; rare laryngeal dystonia may cause stridor and respiratory distress. Neuroleptic malignant syndrome is an uncommon but life-threatening complication marked by hyperthermia, rigidity, altered mental status, autonomic instability, rhabdomyolysis, and renal failure. Clozapine and olanzapine may cause agranulocytosis, and several neuroleptics are associated with hyperglycemia and new-onset diabetes.
Evaluation includes continuous monitoring of vital signs, cardiac rhythm, oxygen saturation, and core temperature. Laboratory studies should assess electrolytes, renal function, glucose, liver enzymes, creatine kinase when neuroleptic malignant syndrome or agitation is suspected, and complete blood count in clozapine exposure. An electrocardiogram is essential to evaluate QT or QRS prolongation.
Management is primarily supportive, with early attention to airway, breathing, and circulation. Supplemental oxygen, intravenous access, glucose assessment, and intubation for respiratory compromise are critical. Activated charcoal may be given within one hour of ingestion if the airway is protected. Hypotension is treated with intravenous fluids and vasopressors such as norepinephrine if refractory. Dystonic reactions respond rapidly to diphenhydramine or benztropine, continued for several days to prevent recurrence. Seizures are treated with benzodiazepines, with phenobarbital for refractory cases. Suspected neuroleptic malignant syndrome requires immediate discontinuation of the offending agent, aggressive cooling, benzodiazepines, intravenous fluids, and consideration of bromocriptine or dantrolene in severe cases.
Patients with significant symptoms, abnormal vital signs, central nervous system depression, dysrhythmias, or suspected neuroleptic malignant syndrome require admission, often to an intensive care unit. Asymptomatic patients may be discharged after adequate observation, with longer monitoring for delayed-onset agents or extended-release formulations. Intentional overdoses require psychiatric evaluation, while accidental exposures warrant poison prevention counseling.
- Published on
KembaraXtra -Medicine- Nephrotic Syndrome
Nephrotic syndrome is a clinical disorder caused by defects in the glomerular filtration barrier that lead to heavy protein loss in the urine. It is defined by nephrotic-range proteinuria greater than 3 g per 24 hours, hypoalbuminemia with serum albumin below 3 g/dL, peripheral edema, hyperlipidemia, lipiduria with oval fat bodies and fatty casts, and associated hypogammaglobulinemia. The altered glomerular basement membrane becomes excessively permeable due to immune complexes, nephrotoxic antibodies, or nonimmune mechanisms, allowing loss of albumin and other large proteins.
The pathophysiology centers on increased glomerular protein filtration and reduced plasma oncotic pressure, resulting in sodium and water retention and edema. Severe hypoalbuminemia may cause postural hypotension, syncope, or shock. Hyperlipidemia develops as hepatic lipoprotein synthesis increases in response to low oncotic pressure. Patients are at increased risk of thromboembolic events, particularly when serum albumin is very low, protein excretion is high, fibrinogen levels are elevated, and antithrombin III levels are reduced.
Nephrotic syndrome may arise from primary renal diseases or secondary systemic conditions. In adults, membranous nephropathy is the most common primary cause and may be associated with chronic infections such as hepatitis B or C or autoimmune disease. Minimal change disease accounts for most pediatric cases and typically responds well to corticosteroids. Focal segmental glomerulosclerosis affects adolescents and young adults and may be primary or secondary to conditions such as HIV, obesity, or heroin use. Diabetic nephropathy is the most common secondary cause in adults and is heralded by microalbuminuria. Other causes include systemic lupus erythematosus, monoclonal gammopathies such as amyloidosis and multiple myeloma, HIV-associated nephropathy, preeclampsia, hepatitis, and drug-induced disease.
Clinical presentation varies widely. Many patients are asymptomatic aside from foamy urine and gradual weight gain from fluid retention. Edema may range from mild pitting edema to generalized anasarca with ascites and pleural effusions. Hypertension or hypotension may occur depending on intravascular volume status. Hematuria may be present, particularly with renal vein thrombosis. Acute dyspnea, tachycardia, or hypotension should raise concern for pulmonary embolism, a recognized complication of the hypercoagulable state.
Evaluation begins with urinalysis demonstrating heavy proteinuria and lipiduria with oval fat bodies. Laboratory studies reveal hypoalbuminemia, hyperlipidemia, and possible anemia. Quantification of proteinuria is performed with a 24-hour urine collection or protein-to-creatinine ratio. Additional testing is guided by suspected systemic disease and may include autoimmune markers, hepatitis serologies, and serum or urine protein electrophoresis. Renal ultrasound is useful in secondary causes, and renal biopsy is the definitive diagnostic test when response to steroids is poor or etiology is unclear.
Management focuses on treating the underlying cause and controlling complications. Sodium restriction and cautious diuresis with loop diuretics are used to manage edema, avoiding overly aggressive fluid removal to prevent renal failure and thrombosis. ACE inhibitors or ARBs reduce proteinuria and slow progression of renal disease. Corticosteroids are the mainstay for primary nephrotic syndromes, particularly minimal change disease. Anticoagulation is indicated for confirmed thromboembolic events and may be considered prophylactically in patients with profound hypoalbuminemia. Lipid-lowering therapy and nutritional support are important adjuncts.
Hospital admission is required for patients with severe edema, respiratory compromise, acute renal failure, thromboembolic complications, or significant comorbid disease. Stable patients without complications may be managed as outpatients with close nephrology follow-up. Long-term prognosis depends on the underlying cause, degree of proteinuria, blood pressure control, and response to therapy, with vigilant monitoring essential to reduce complications and progression to chronic kidney disease.
- Published on
Emergency and Acute Medicine – Otologic Trauma
Otologic trauma involves injury to the external, middle, or inner ear and may result from blunt, penetrating, barotrauma, thermal, chemical, or blast mechanisms. Injuries to the pinna are particularly concerning because auricular cartilage lacks a direct blood supply and depends on the perichondrium for nutrition. Disruption of this relationship, especially from hematoma formation, can lead to ischemia, perichondritis, cartilage necrosis, and permanent deformity such as cauliflower ear. Penetrating injuries and bite wounds increase the risk of cartilage infection.
The middle ear is an air-filled cavity containing the ossicles and is vulnerable to pressure-related injuries such as blasts or diving accidents. Because it is bordered by the temporal and mastoid bones and adjacent to the cranial vault, fractures in this region may result in cerebrospinal fluid otorrhea or rhinorrhea and disruption of the vestibular system. The facial nerve traverses the middle ear, and injury can result in peripheral facial nerve paralysis. Pediatric patients with otologic trauma should always be evaluated for possible nonaccidental injury.
Patients may present with severe ear pain, bleeding, or visible deformity of the auricle. Auricular hematomas typically appear as bluish, fluctuant, or doughy swellings of the pinna and are associated with loss of normal contour. Lacerations, partial avulsions, or complete amputations may be seen. Signs of middle ear trauma include decreased hearing, tinnitus, vertigo, nystagmus, facial nerve weakness, and canal drainage. Partial hearing loss suggests tympanic membrane rupture, whereas complete hearing loss raises concern for ossicular chain or inner ear injury. Findings suggestive of basilar skull fracture include hemotympanum, Battle sign, and cerebrospinal fluid leakage from the ear or nose.
History should focus on the mechanism of injury, associated trauma, prior otologic disease, and medication use. Physical examination must include a complete head and neck evaluation with careful inspection of the pinna, external auditory canal, tympanic membrane, cranial nerves, and hearing assessment. Tuning fork tests such as Weber and Rinne are useful to differentiate conductive from sensorineural hearing loss. Concomitant injuries must always be excluded in trauma patients.
Diagnosis is primarily clinical. Wound cultures are reserved for signs of infection. Imaging with head or facial CT is indicated when intracranial injury or skull fracture is suspected, while CT of the temporal bone without contrast is recommended for significant middle ear injury or facial nerve involvement.
Initial management begins with standard trauma assessment and stabilization, including airway, breathing, and circulation. Injured ears should be covered with sterile dressings. If the auricle is amputated, it should be wrapped in moist gauze, placed in a plastic bag, and kept cool for possible reattachment. Adequate anesthesia is essential and may be achieved through auricular nerve blocks or a circumferential ring block at the base of the pinna.
Auricular hematomas require prompt drainage, ideally within 72 hours, to reapproximate the perichondrium and cartilage and prevent necrosis. Small, nonclotted hematomas may be aspirated, while larger or clotted collections are best managed with incision and drainage followed by a firm pressure dressing. Antistaphylococcal antibiotics are typically given for 7–10 days. Reaccumulation requires repeat drainage and possibly wick placement.
Lacerations should be thoroughly cleaned and debrided. Simple lacerations can be closed with nonabsorbable monofilament sutures and a pressure dressing, while exposed cartilage must be carefully covered to prevent perichondritis. Human or animal bite wounds warrant prophylactic antibiotics, most commonly amoxicillin–clavulanate. Small avulsions less than 2 cm may survive as grafts, but larger avulsions require urgent consultation with otolaryngology or plastic surgery.
Patients may be discharged if they can tolerate oral antibiotics, have no serious associated injuries, and can ensure close follow-up. Admission is indicated for patients with significant associated trauma, immunosuppression with infection, perichondritis, chondritis, or need for intravenous antibiotics. Follow-up is recommended within 24 hours for auricular hematomas to assess for reaccumulation and within five days for suture evaluation or removal.
A key clinical principle is that failure to promptly recognize and adequately treat auricular hematomas can result in permanent deformity. Early drainage, proper pressure dressing, and close follow-up are essential to prevent long-term complications.
- Published on
Emergency and Acute Medicine – Paget Disease
Paget disease, also known as osteitis deformans, is a disorder of bone remodeling characterized by excessive resorption of normal bone followed by replacement with disorganized, fibrous, and sclerotic bone. The disease is usually focal and most commonly affects the pelvis, femur, skull, tibia, and spine, particularly the lumbar spine. It occurs in approximately 1–2% of individuals older than 55 years, with incidence increasing with age. Many patients are asymptomatic, and the disease is often discovered incidentally on radiographs or through elevated alkaline phosphatase levels.
The disease begins with an osteolytic phase in which osteoclasts aggressively resorb healthy bone. This phase is associated with increased bone vascularity, predisposing patients to hematoma formation and pathologic fractures. Over time, the resorbed bone is replaced by dense, irregular trabecular bone in the osteoplastic phase, forming a characteristic mosaic pattern. Although malignant transformation is rare, occurring in about 1% of cases, osteosarcoma is the primary malignancy of concern. Paget disease is more common in men and individuals of European descent and is rare in children.
The etiology remains unclear, though both genetic and environmental factors are implicated. Mutations in the SQSTM1 gene have been identified in many cases, and viral inclusions seen in osteoclasts suggest a possible association with paramyxoviruses. Environmental factors such as rural living and exposure to farm animals may also contribute.
Clinical presentation varies widely. Many patients remain asymptomatic, while others develop deep, aching bone pain later in the disease course. Pain may worsen with weight bearing when the femur or tibia is involved or with rest when non–weight-bearing bones are affected. During the acute osteolytic phase, patients are at risk for pathologic fractures, hypercalcemia, renal stones, and bleeding due to hypervascular bone. In widespread disease, increased bone blood flow may lead to high-output cardiac failure. In the osteoplastic phase, long-bone involvement can cause deformity, gait abnormalities, and swelling. Skull involvement may lead to headaches, cranial nerve compression, hearing loss, or changes in head size, while spinal disease can cause neurologic compression.
Diagnosis is usually suggested by characteristic radiographic findings and supported by laboratory abnormalities. Alkaline phosphatase is the most sensitive marker of disease activity, while calcium and phosphate levels are typically normal unless complications such as fracture or immobilization occur. Imaging with plain radiographs often reveals lytic lesions, bone expansion, cortical thickening, or dense “ivory” bone. Radionuclide bone scans are useful to assess the extent and activity of disease, while CT or MRI helps evaluate complications such as neoplasm, hematoma, or spinal cord compression.
Emergency management focuses on complications rather than the underlying disease. Pathologic fractures require prompt immobilization to limit bleeding, and analgesia is provided with acetaminophen or opioids. Hypercalcemia is treated with intravenous fluids, calcitonin, and bisphosphonates as needed. Suspected neurologic compromise mandates urgent neurosurgical consultation. Definitive medical therapy is indicated for symptomatic patients or those with disease in high-risk locations and typically involves nitrogen-containing bisphosphonates such as alendronate, risedronate, pamidronate, or zoledronic acid.
Admission is indicated for patients with major trauma, significant bleeding, hypercalcemia, high-output cardiac failure, or neurologic compression. Stable patients with adequate pain control and no acute complications may be discharged with appropriate orthopedic and endocrinology follow-up. A key clinical pearl is that Paget disease is often an incidental diagnosis, and unexplained elevation of alkaline phosphatase or pathologic fracture in an older adult should prompt consideration of this condition.
